Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 1638,"Korbolina EE, et al., Aging (Albany NY). 2012 Jan;4(1):49-59.",retina integrity trait,,RS:0000634,OXYS/Nov,male,90 days,36,,CMO:0002453,percentage of study population developing retinopathy during a period of time,,,,0.0247,%,0.0024,0.0144,MMO:0000551,slit-lamp direct ophthalmoscopy,,0.0,Beta direct ophthalmoscope (Germany),,,,control condition,85622,control condition 1638,"Korbolina EE, et al., Aging (Albany NY). 2012 Jan;4(1):49-59.",retina integrity trait,,RS:0000634,OXYS/Nov,female,90 days,25,,CMO:0002453,percentage of study population developing retinopathy during a period of time,,,,0.0464,%,0.0028,0.014,MMO:0000551,slit-lamp direct ophthalmoscopy,,0.0,Beta direct ophthalmoscope (Germany),,,,control condition,85623,control condition